The Trump administration has indicated that it will fund a $1.6m study on hepatitis B vaccination of newborns in the west African country of Guinea-Bissau, where nearly one in five adults live with the virus – a move that researchers call…
US plan for $1.6m hepatitis B vaccine study in Africa called ‘highly unethical’ | Vaccines and immunisation
